R Ananthanarayanan

R Ananthanarayanan, PhD, currently serves as the Chief Executive Officer at Teva Active Pharmaceutical Ingredients since November 2023. Prior to this role, R Ananthanarayanan was the Whole-Time Director and Chief Executive Officer at Sajjan India Ltd from May 2022 to November 2023 and held the position of Managing Director and Chief Executive Officer at Strides from January 2020 to March 2022. R Ananthanarayanan's extensive experience also includes serving as President and Global Chief Operating Officer at Cipla, President and CEO of Teva API & Biologics, and President at Dr. Reddy's Laboratories. R Ananthanarayanan has a strong background in the pharmaceutical sector with previous roles at Piramal Enterprises Limited, Galpharm International, and Zydus Cadila. R Ananthanarayanan holds a Ph.D. and a B.S. in Pharmaceutical Sciences from the University of Mumbai.